Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers

BACKGROUND: Ribonucleotide reductase (RR) is an essential enzyme involved in DNA synthesis. We hypothesized that RR subunit M2 (RRM2) might be a novel prognostic and predictive biomarker for estrogen receptor (ER)-negative breast cancers. METHODS: Individual and pooled survival analyses were conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hang, Liu, Xiyong, Warden, Charles D, Huang, Yasheng, Loera, Sofia, Xue, Lijun, Zhang, Suzhan, Chu, Peiguo, Zheng, Shu, Yen, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171582/
https://www.ncbi.nlm.nih.gov/pubmed/25213022
http://dx.doi.org/10.1186/1471-2407-14-664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171582/
https://www.ncbi.nlm.nih.gov/pubmed/25213022
http://dx.doi.org/10.1186/1471-2407-14-664

Ejemplares similares